Dihydropyridine derivatives as bradykinin antagonist
申请人:Pfizer Inc.
公开号:US05859011A1
公开(公告)日:1999-01-12
Compound of formula (1) and their pharmaceutically acceptable salts wherein A1,A2,R1, R2,R3,R4,X are as defined in the specification have excellent bradykinin antagonistic activity. ##STR1##